---
title: "Windward Bio prices $175 million Nasdaq IPO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305634890.md"
description: "Windward Bio priced a $175 million Nasdaq IPO, excluding the greenshoe option. A concurrent $50 million private placement with Sanofi brings total expected gross proceeds to $225 million. Novo Holdings invested in Windward in January 2025. The company develops ultra-long-acting antibodies for respiratory and dermatological diseases, with lead candidate WIN378 showing positive interim asthma results and initiating Phase 3 trials in September 2026."
datetime: "2026-11-16T08:09:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305634890.md)
  - [en](https://longbridge.com/en/news/305634890.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305634890.md)
generator: "portal-rs"
---

# Windward Bio prices $175 million Nasdaq IPO

-   Windward Bio priced a $175 million Nasdaq IPO, excluding the greenshoe option. \* A concurrent $50 million private placement with Sanofi brings expected gross proceeds from both transactions to $225 million. \* Novo Holdings invested in Windward in January 2025. \* In September 2026, Windward reported positive interim asthma results for WIN378 and initiated Phase 3. \* Windward develops ultra-long-acting antibodies for respiratory and dermatological diseases; lead candidate WIN378 is designed for twice-yearly dosing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Holdings A/S published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [WWB.US](https://longbridge.com/en/quote/WWB.US.md)
- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)

## Related News & Research

- [Novo Holdings-backed Windward Bio valued at $1 billion as shares rise in Nasdaq debut](https://longbridge.com/en/news/305492826.md)
- [Innovative Immunology Biotech Windward Bio Lists on Nasdaq](https://longbridge.com/en/news/305550818.md)
- [Windward Bio Presents at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/305870877.md)
- [Windward Bio Raises $50 Million in Private Placement to Sanofi Foreign Participations](https://longbridge.com/en/news/305719353.md)
- [Eli Lilly (LLY) Enters Cancer Licensing Deal Worth $5.9 Billion](https://longbridge.com/en/news/305855448.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**